Cargando…
Left atrial appendage thrombus on full-dose dabigatran treatment: a case report
BACKGROUND: Dabigatran is a direct competitive thrombin inhibitor approved for stroke prevention in non-valvular atrial fibrillation. At full-dose, dabigatran showed similar rates of bleedings and higher efficacy compared to warfarin. CASE SUMMARY: We report a case of acute ischaemic stroke in a pat...
Autores principales: | Candelaresi, Paolo, Iannuzzi, Angela, Servillo, Giovanna, Gottilla, Rossella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319812/ https://www.ncbi.nlm.nih.gov/pubmed/32617467 http://dx.doi.org/10.1093/ehjcr/ytaa057 |
Ejemplares similares
-
Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban
por: Miwa, Yosuke, et al.
Publicado: (2016) -
Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013) -
A left atrial appendage thrombus that developed during prophylactic low‐dose dabigatran treatment resolved after switching to apixaban
por: Koyama, Taku, et al.
Publicado: (2017) -
Anticoagulation efficacy of dabigatran etexilate for left atrial appendage thrombus in patients with atrial fibrillation by transthoracic and transesophageal echocardiography
por: Xing, Xiao Fei, et al.
Publicado: (2018) -
Resolution of left atrial appendage thrombus with apixaban
por: Kawakami, Tohru, et al.
Publicado: (2013)